Brind.

Entities / Person

Ana Szarfman.

researcher

Seen in 2 reportsLast reported Jun 20

Reports this week: 0
Active events: 0
Connections: 2

What's happening

Gone quiet

No new reports in 90+ days

Allegations surfaced that FDA officials, including a safety data-mining expert, were involved in oversight failures regarding vaccine safety signals related to Moderna.

Some support1 report1 development inside

Around Ana Szarfman this week

News at the entities that move Ana Szarfman most

FDA Transactional
Generic medicine services are seeking approval for launch from the FDA.

Moves Ana Szarfman
Mon 17:49
Control Data Corporation Mentioned together
The Securities and Exchange Commission (SECP) guides the digital initiative of Control Data Corporation (CDCPL), which operates within the Pakistani market. Sidhu chaired the relevant meeting.

Moves Ana Szarfman
Sun 11:40

Connections

Strongest first. The bars show how strongly a change on one side reaches the other.

FDA Transactional

Ana Szarfman served as a safety data-mining expert at the FDA.

Some supportJun 20

Ana Szarfman → FDA
FDA → Ana Szarfman
Control Data Corporation Mentioned together

The entities were co-mentioned in articles discussing shared involvement in vaccine safety failures.

Some supportJun 20

Ana Szarfman → Control Data Corporation
Control Data Corporation → Ana Szarfman

History

Events by the month they began

June 2026

1 event

Jun 20, 2026Allegations surfaced that FDA officials, including a safety data-mining expert, were involved in oversight failures regarding vaccine safety signals related to Moderna.